Abstract
BACKGROUND Epidemiological studies demonstrate higher loneliness is associated with increased risk of developing cardiovascular disease (CVD). However, most studies are conducted with populations in Western developed countries, whose cultures generally emphasize independence. Less clear is whether these associations are also evident in more interdependent cultures, such as those in East Asian countries. We hypothesized feeling lonely could be more stressful and exhibit stronger associations with CVD risk in a highly interdependent versus independent culture.
METHODS We examined associations of loneliness with fatal and non-fatal CVD incidence in older adults from the Health and Retirement Study (HRS; n =13,073) conducted in the U.S. and from the Korean Longitudinal Study of Aging (KLoSA; n=8,311) conducted in South Korea. In both cohorts, baseline loneliness was assessed using one item from the Center for Epidemiologic Studies Depression Scale. Incident CVD was defined as reporting new-onset CVD on the biennial questionnaire or CVD death reported by proxies. Within each cohort, we estimated adjusted hazard ratios (aHR) of incident CVD according to loneliness (yes/no) over 12-14 years of follow-up, adjusting for relevant baseline covariates, including social isolation, sociodemographic factors, health conditions, and health behaviors. We further examined health behaviors as a potential pathway underlying these associations using counterfactual mediation analyses.
RESULTS Controlling for all covariates, feeling lonely was associated with an increased likelihood of developing CVD in the U.S. (aHR:1.15, 95%CI: 1.04,1.27) and in South Korea (aHR: 1.16, 95%CI: 1.00, 1.34). The pooled analysis showed no heterogeneity (Q=0.009, p=0.92), and the HR for loneliness was 1.14 (95% CI: 1.05-1.23). Regarding potential mediators, several behaviors accounted for a proportion of the association: physical activity, in both countries (14.6%, p=0.03 in HRS; 1.3%, p = 0.04 in KLoSA), alcohol consumption only in KLoSA (1.1%, p < 0.001), smoking only in HRS (4.7%, p < 0.001).
CONCLUSIONS AND RELEVANCE Contrary to our hypothesis, the magnitude of the loneliness-CVD relationship was similar in both countries, with 14% higher odds of developing CVD, while behavioral pathways appeared different. Loneliness may be a risk factor for CVD regardless of culture; however, different prevention strategies in clinical settings may be required.
Clinical Perspective What is New?
Even after controlling for social isolation, health behaviors/conditions, and sociodemographic factors, feeling lonely was associated with an increased likelihood of developing CVD among older adults in both the U.S. (15% increase) and South Korea (16% increase).
The impact of loneliness on CVD risk did not appear to differ substantially by culture, comparing individuals from a more independent versus interdependent culture.
The behaviors linking loneliness and CVD differed somewhat between the U.S. and South Korea, suggesting cultural factors may contribute to shaping distinct behavioral pathways through which loneliness impacts health.
What are the clinical implications?
A consistent association between loneliness and CVD risk was evident in two very different cultures, suggesting loneliness may be a relevant target for CVD prevention strategies in diverse populations.
While the associations are modest, the public health implications of loneliness-related CVD could be significant if a substantial portion of the population experiences loneliness, particularly in the aftermath of the COVID-19 pandemic.
Assessing loneliness levels may provide healthcare professionals with greater insight into patients’ CVD risk.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This was not a clinical trial
Funding Statement
National Institute on Aging R24AG048024; R01AG030153).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is a secondary data analysis using publicly available datasets. The current work does not involve any identifiable data or HIPAA considerations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.